1562. Reduction in Healthcare Utilization and Overdose after Skin and Soft Tissue Infections for Injection Drug Users through Addiction Medicine Consultation

por Bielick, Catherine G, Knodle, Ryan D, Burrowes, Shana, Barlam, Tamar F
Publicado 2020

End-stage kidney disease and COVID-19 in an urban safety-net hospital in Boston, Massachusetts

por Kamel, Mohamed Hassan, Mahmoud, Hassan, Zhen, Aileen, Liu, Jing, Bielick, Catherine G., Mostaghim, Anahita, Lin, Nina, Chitalia, Vipul, Ilori, Titilayo, Waikar, Sushrut S., Upadhyay, Ashish
Publicado 2021

The Effect of IL-6 Inhibitors on Mortality Among Hospitalized COVID-19 Patients: A Multicenter Study

por Sinha, Pranay, Jafarzadeh, S Reza, Assoumou, Sabrina A, Bielick, Catherine G, Carpenter, Bethanne, Garg, Shivani, Harleen, Sahni, Neogi, Tuhina, Nishio, Midori Jane, Sagar, Manish, Sharp, Veronika, Kissin, Eugene Y
Publicado 2020

Early administration of interleukin-6 inhibitors for patients with severe COVID-19 disease is associated with decreased intubation, reduced mortality, and increased discharge

por Sinha, Pranay, Mostaghim, Anahita, Bielick, Catherine G., McLaughlin, Angela, Hamer, Davidson H., Wetzler, Lee M., Bhadelia, Nahid, Fagan, Maura A., Linas, Benjamin P., Assoumou, Sabrina A., Ieong, Michael H., Lin, Nina H., Cooper, Ellen R., Brade, Karrine D., White, Laura F., Barlam, Tamar F., Sagar, Manish
Publicado 2020